Osteocytes and Paget's Disease of Bone.

Osteoclast Osteocyte Paget’s bone disease RANKL Senescence

Journal

Current osteoporosis reports
ISSN: 1544-2241
Titre abrégé: Curr Osteoporos Rep
Pays: United States
ID NLM: 101176492

Informations de publication

Date de publication:
08 Mar 2024
Historique:
accepted: 09 02 2024
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

To describe the contributions of osteocytes to the lesions in Paget's disease, which are characterized by locally overactive bone resorption and formation. Osteocytes, the most abundant cells in bone, are altered in Paget's disease lesions, displaying increased size, decreased canalicular length, incomplete differentiation, and less sclerostin expression compared to controls in both patients and mouse models. Pagetic lesions show increased senescent osteocytes that express RANK ligand, which drives osteoclastic bone resorption. Abnormal osteoclasts in Paget's disease secrete abundant IGF1, which enhances osteocyte senescence, contributing to lesion formation. Recent data suggest that osteocytes contribute to lesion formation in Paget's disease by responding to high local IGF1 released from abnormal osteoclasts. Here we describe the characteristics of osteocytes in Paget's disease and their role in bone lesion formation based on recent results with mouse models and supported by patient data.

Identifiants

pubmed: 38457001
doi: 10.1007/s11914-024-00863-5
pii: 10.1007/s11914-024-00863-5
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : NIH R01-AR057308
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016059
Pays : United States

Informations de copyright

© 2024. The Author(s).

Auteurs

Hirofumi Tenshin (H)

Division of Hematology and Oncology, Department of Medicine, Indiana University, Indianapolis, IN, USA.

Jesus Delgado-Calle (J)

Department of Physiology and Cell Biology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Jolene J Windle (JJ)

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA.

G David Roodman (GD)

Division of Hematology and Oncology, Department of Medicine, Indiana University, Indianapolis, IN, USA.

John M Chirgwin (JM)

Division of Hematology and Oncology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Research Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.

Noriyoshi Kurihara (N)

Division of Hematology and Oncology, Department of Medicine, Indiana University, Indianapolis, IN, USA. norikuri@iu.edu.

Classifications MeSH